nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—Hyperkalaemia—Varenicline—nicotine dependence	0.0448	0.0545	CcSEcCtD
Candesartan—Angina pectoris—Varenicline—nicotine dependence	0.0279	0.0339	CcSEcCtD
Candesartan—Bronchitis—Varenicline—nicotine dependence	0.0275	0.0335	CcSEcCtD
Candesartan—Hyperglycaemia—Varenicline—nicotine dependence	0.0258	0.0314	CcSEcCtD
Candesartan—Acute coronary syndrome—Varenicline—nicotine dependence	0.0252	0.0306	CcSEcCtD
Candesartan—Myocardial infarction—Varenicline—nicotine dependence	0.025	0.0304	CcSEcCtD
Candesartan—Epistaxis—Varenicline—nicotine dependence	0.0241	0.0293	CcSEcCtD
Candesartan—Sinusitis—Varenicline—nicotine dependence	0.0239	0.0291	CcSEcCtD
Candesartan—Urinary tract disorder—Varenicline—nicotine dependence	0.0226	0.0275	CcSEcCtD
Candesartan—Oedema peripheral—Varenicline—nicotine dependence	0.0226	0.0274	CcSEcCtD
Candesartan—Urethral disorder—Varenicline—nicotine dependence	0.0225	0.0273	CcSEcCtD
Candesartan—Mental disorder—Varenicline—nicotine dependence	0.0201	0.0244	CcSEcCtD
Candesartan—Malnutrition—Varenicline—nicotine dependence	0.0199	0.0242	CcSEcCtD
Candesartan—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0198	0.112	CbGpPWpGaD
Candesartan—Back pain—Varenicline—nicotine dependence	0.0193	0.0234	CcSEcCtD
Candesartan—Anaemia—Varenicline—nicotine dependence	0.0184	0.0224	CcSEcCtD
Candesartan—Angioedema—Varenicline—nicotine dependence	0.0182	0.0222	CcSEcCtD
Candesartan—Vertigo—Varenicline—nicotine dependence	0.0179	0.0218	CcSEcCtD
Candesartan—Palpitations—Varenicline—nicotine dependence	0.0176	0.0214	CcSEcCtD
Candesartan—Cough—Varenicline—nicotine dependence	0.0174	0.0212	CcSEcCtD
Candesartan—Hypertension—Varenicline—nicotine dependence	0.0172	0.0209	CcSEcCtD
Candesartan—Arthralgia—Varenicline—nicotine dependence	0.017	0.0206	CcSEcCtD
Candesartan—Chest pain—Varenicline—nicotine dependence	0.017	0.0206	CcSEcCtD
Candesartan—Myalgia—Varenicline—nicotine dependence	0.017	0.0206	CcSEcCtD
Candesartan—Anxiety—Varenicline—nicotine dependence	0.0169	0.0206	CcSEcCtD
Candesartan—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0162	0.091	CbGpPWpGaD
Candesartan—Thrombocytopenia—Varenicline—nicotine dependence	0.0159	0.0194	CcSEcCtD
Candesartan—Tachycardia—Varenicline—nicotine dependence	0.0159	0.0193	CcSEcCtD
Candesartan—Hyperhidrosis—Varenicline—nicotine dependence	0.0157	0.0191	CcSEcCtD
Candesartan—Hypotension—Varenicline—nicotine dependence	0.0152	0.0185	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.0148	0.018	CcSEcCtD
Candesartan—Dyspnoea—Varenicline—nicotine dependence	0.0145	0.0176	CcSEcCtD
Candesartan—Somnolence—Varenicline—nicotine dependence	0.0145	0.0176	CcSEcCtD
Candesartan—Dyspepsia—Varenicline—nicotine dependence	0.0143	0.0174	CcSEcCtD
Candesartan—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0141	0.0171	CcSEcCtD
Candesartan—Fatigue—Varenicline—nicotine dependence	0.014	0.0171	CcSEcCtD
Candesartan—Gastrointestinal pain—Varenicline—nicotine dependence	0.0133	0.0162	CcSEcCtD
Candesartan—Urticaria—Varenicline—nicotine dependence	0.0129	0.0157	CcSEcCtD
Candesartan—Abdominal pain—Varenicline—nicotine dependence	0.0129	0.0156	CcSEcCtD
Candesartan—Body temperature increased—Varenicline—nicotine dependence	0.0129	0.0156	CcSEcCtD
Candesartan—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.0123	0.0693	CbGpPWpGaD
Candesartan—Asthenia—Varenicline—nicotine dependence	0.0117	0.0142	CcSEcCtD
Candesartan—Pruritus—Varenicline—nicotine dependence	0.0115	0.014	CcSEcCtD
Candesartan—Diarrhoea—Varenicline—nicotine dependence	0.0111	0.0135	CcSEcCtD
Candesartan—Dizziness—Varenicline—nicotine dependence	0.0108	0.0131	CcSEcCtD
Candesartan—Vomiting—Varenicline—nicotine dependence	0.0103	0.0126	CcSEcCtD
Candesartan—Rash—Varenicline—nicotine dependence	0.0103	0.0125	CcSEcCtD
Candesartan—Dermatitis—Varenicline—nicotine dependence	0.0103	0.0125	CcSEcCtD
Candesartan—Headache—Varenicline—nicotine dependence	0.0102	0.0124	CcSEcCtD
Candesartan—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.01	0.0564	CbGpPWpGaD
Candesartan—Nausea—Varenicline—nicotine dependence	0.00967	0.0118	CcSEcCtD
Candesartan—AGTR1—Peptide GPCRs—OPRM1—nicotine dependence	0.00839	0.0473	CbGpPWpGaD
Candesartan—UGT1A3—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00641	0.0362	CbGpPWpGaD
Candesartan—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00641	0.0361	CbGpPWpGaD
Candesartan—UGT1A3—Biological oxidations—CYP2A7—nicotine dependence	0.00605	0.0341	CbGpPWpGaD
Candesartan—UGT1A3—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00596	0.0336	CbGpPWpGaD
Candesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00511	0.0288	CbGpPWpGaD
Candesartan—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00504	0.0284	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00478	0.0269	CbGpPWpGaD
Candesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00416	0.0234	CbGpPWpGaD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00414	0.0233	CbGpPWpGaD
Candesartan—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0041	0.0231	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00394	0.0222	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.00341	0.0192	CbGpPWpGaD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00337	0.019	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00309	0.0174	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0027	0.0152	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00265	0.0149	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00245	0.0138	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00233	0.0132	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00223	0.0126	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.0022	0.0124	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00217	0.0122	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—FGD1—nicotine dependence	0.00212	0.0119	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—OPRM1—nicotine dependence	0.00201	0.0114	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—FGD1—nicotine dependence	0.00192	0.0109	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00191	0.0108	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0019	0.0107	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.00179	0.0101	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00177	0.00995	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—DRD2—nicotine dependence	0.00146	0.00821	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TAS2R16—nicotine dependence	0.00145	0.00817	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—OPRM1—nicotine dependence	0.00114	0.00642	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FGD1—nicotine dependence	0.00114	0.00641	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—OPRM1—nicotine dependence	0.00103	0.00583	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP2A7—nicotine dependence	0.00103	0.00583	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKR1B10—nicotine dependence	0.001	0.00566	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—DRD2—nicotine dependence	0.000823	0.00464	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—DRD2—nicotine dependence	0.000748	0.00421	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—WASF2—nicotine dependence	0.000708	0.00399	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.0007	0.00394	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—WASF1—nicotine dependence	0.000678	0.00382	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—OPRM1—nicotine dependence	0.000611	0.00344	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP2A7—nicotine dependence	0.000582	0.00328	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—DRD2—nicotine dependence	0.000442	0.00249	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000376	0.00212	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000328	0.00185	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000306	0.00173	CbGpPWpGaD
